
STC Pharmaceuticals Private Limited
About STC Pharmaceuticals Private Limited
Data last updated:
STC Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 09 March 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2024PTC428051.
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ranjeet Kumar and Nand Kishor Nandan.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 200 First Floor Cycle Market Dda Complex, Jhandewalan Extn., New Delhi, Delhi, India – 110055.
Company details
Contact details
STC Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressOffice No. 200 First Floor Cycle Market Dda Complex, Jhandewalan Extn., New Delhi, Delhi, India – 110055
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of STC Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of STC Pharmaceuticals Private Limited, buy the company report.
Board of directors of STC Pharmaceuticals Private Limited
STC Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjeet Kumar | Director | 09 Mar 2024 | 2 Years 7 Months | Current |
| Nand Kishor Nandan | Director | 05 Sep 2024 | 2 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving STC Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for STC Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for STC Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
STC Pharmaceuticals Private Limited has 3 board changes on record since 2024: 2 appointments and 1 cessation. The latest: Kanhaiya Kumar Choursiya ceased to be Director on 09 Sep 2024.
Frequently asked questions
STC Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 09 March 2024 (2+ years old) and is registered under CIN U21001DL2024PTC428051.
STC Pharmaceuticals has 2 current directors:
- Ranjeet Kumar - Director
- Nand Kishor Nandan - Director
The latest financial statements of STC Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of STC Pharmaceuticals is U21001DL2024PTC428051. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
STC Pharmaceuticals was incorporated on 09 March 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
Kanhaiya Kumar Choursiya ceased to be Director on 09 Sep 2024. Nand Kishor Nandan was appointed as Director on 05 Sep 2024. Ranjeet Kumar was appointed as Director on 09 Mar 2024.
The registered office of STC Pharmaceuticals is at Office No. 200 First Floor Cycle Market Dda Complex, Jhandewalan Extn., New Delhi, Delhi, India – 110055.
STC Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
STC Pharmaceuticals can be reached at its registered office: Office No. 200 First Floor Cycle Market Dda Complex, Jhandewalan Extn, New Delhi, Delhi, India – 110055.
STC Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

